Enhancing Antigen Cross-Presentation and T-Cell Priming by Complexing Protein Antigen to Recombinant Large Heat-Shock Protein

Methods in Molecular Biology

Volumn 787, Issue , 2011, Pages 277-287

  Wang, Xiang Yang ^a   Yi, Huanfa ^a   Yu, Xiaofei ^a   Zuo, Damin ^a   Subjeck, John R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Antigen presentation; Chaperone vaccine; grp170; hsp110; Large heat shock protein; T cell priming

Indexed keywords

CANCER VACCINE; CHAPERONE; GLUCOSE REGULATED PROTEIN 170; GLUCOSE-REGULATED PROTEIN 170; GLYCOPROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 70; RECOMBINANT PROTEIN;

ANIMAL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BACULOVIRUS; CROSS PRESENTATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PROTEIN FOLDING; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BACULOVIRIDAE; CANCER VACCINES; CROSS-PRIMING; GLYCOPROTEINS; HSP110 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; PROTEIN FOLDING; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 80054754468     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-295-3_21     Document Type: Chapter

References (22)

1. Welch WJ. Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Philos Trans R Soc Lond B Biol Sci 1993;339:327–33.
2. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997;278:117–20.
3. Graner M, Raymond A, Romney D, He L, Whitesell L, Katsanis E. Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma. Clin Cancer Res 2000;6:909–15.
4. Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001;166:490–7.
5. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002;20: 395–425.
6. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immunol 2000;1:151–5.
7. Delneste Y, Magistrelli G, Gauchat J, et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002;17: 353–62.
8. Berwin B, Hart JP, Rice S, et al. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. Embo J 2003;22:6127–36.
9. Facciponte JG, Wang XY, Subjeck JR. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. Eur J Immunol 2007;37:2268–79.
10. Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000;6:435–42.
11. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002;277: 15107–12.
12. Wang XY, Facciponte JG, Subjeck JR. Molecular chaperones and cancer immunotherapy. Handb Exp Pharmacol 2006;172:305–29.
13. Easton DP, Kaneko Y, Subjeck JR. The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones 2000;5:276–90.
14. Oh HJ, Chen X, Subjeck JR. Hsp110 protects heat-denatured proteins and confers cellular thermoresistance. J Biol Chem 1997;272: 31636–40.
15. Park J, Easton DP, Chen X, MacDonald IJ, Wang XY, Subjeck JR. The chaperoning properties of mouse grp170, a member of the third family of hsp70 related proteins. Biochemistry 2003;42:14893–902.
16. Park J, Facciponte JG, Chen X, et al. Chaperoning Function of Stress Protein grp170, a Member of the hsp70 Superfamily, Is Responsible for its Immunoadjuvant Activity. Cancer Res 2006;66:1161–8.
17. Wang XY, Arnouk H, Chen X, Kazim L, Repasky EA, Subjeck JR. Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma. J Immunol 2006;177:1543–51.
18. Manjili MH, Henderson R, Wang XY, et al. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res 2002;62:1737–42.
19. Wang XY, Chen X, Manjili MH, Repasky E, Henderson R, Subjeck JR. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res 2003;63:2553–60.
20. Manjili MH, Wang XY, Chen X, et al. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J Immunol 2003;171:4054–61.
21. Kim H, Sun X, Subjeck J, Wang X-Y. Evaluation of renal cell carcinoma vaccines targeting car-bonic anhydrase IX using heat shock protein 110. Cancer Immunology, Immunotherapy 2007;56:1097–105.
22. Oh HJ, Easton D, Murawski M, Kaneko Y, Subjeck JR. The chaperoning activity of hsp110. Identification of functional domains by use of targeted deletions. J Biol Chem 1999;274:15712–8.